Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Newly Diagnosed Glioblastoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT03250299
What this trial is testing

Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaMGMT-Unmethylated Glioblastoma
Basilea Pharmaceutica 26
Not applicableWithdrawnNCT00645385
What this trial is testing

Examination of Changes on Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS) in Patients Who Receive Gliadel Wafers During Initial Surgery for Glioblastoma Multiforme. Response or Failure to Gliadel Wafers for Subjects With Glioblastoma Multiforme.

Who this might be right for
Glioblastoma MultiformeAnaplastic AstrocytomaAnaplastic Oligodendroglioma
Weill Medical College of Cornell University
Early research (Phase 1)Study completedNCT02010606
What this trial is testing

Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent Glioblastoma

Who this might be right for
GlioblastomaGlioblastoma MultiformeGlioma+2 more
Cedars-Sinai Medical Center 39
Early research (Phase 1)Study completedNCT03224104
What this trial is testing

Multi-kinase Inhibitor TG02 (TG02) in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma.

Who this might be right for
Astrocytoma, Grade IIIGlioblastoma
European Organisation for Research and Treatment of Cancer - EORTC 71
Testing effectiveness (Phase 2)Study completedNCT02366728
What this trial is testing

DC Migration Study for Newly-Diagnosed GBM

Who this might be right for
GlioblastomaAstrocytoma, Grade IVGiant Cell Glioblastoma+1 more
Mustafa Khasraw, MBChB, MD, FRCP, FRACP 64
Large-scale testing (Phase 3)Study completedNCT01364064
What this trial is testing

Conventional Adjuvant Temozolomide With Dose Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
King Faisal Specialist Hospital & Research Center 1,153
Testing effectiveness (Phase 2)Study completedNCT00305864
What this trial is testing

Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma
National Cancer Institute (NCI) 118
Large-scale testing (Phase 3)Study completedNCT00753246
What this trial is testing

Nimotuzumab in Adults With Glioblastoma Multiforma

Who this might be right for
Adults With Glioblastoma Multiforma
Oncoscience AG 150
Very early researchNot Yet RecruitingNCT07778602
What this trial is testing

Safety and Feasibility of First-line Avutometinib and Defactinib in Patients With Newly Diagnosed High-grade Gliomas

Who this might be right for
MGMT-unmethylated Glioblastoma (GBM)IDH Wildtype Glioblastoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 22
Early research (Phase 1)Study completedNCT00053183
What this trial is testing

Surgery Followed by Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI)
Not applicableUnknownNCT03780569
What this trial is testing

TTFields Together With Temozolomide and Radiotherapy in Patients With Newly Diagnosed GBM

Who this might be right for
Glioblastoma Multiforme
NovoCure Ltd. 10
Testing effectiveness (Phase 2)UnknownNCT04600817
What this trial is testing

Evaluate the Efficacy and Safety of TJ107 in Lympopenic Patients With Newly Diagnosed Glioblastoma Who Completed Standard Concurrent Chemoradiotherapy (CCRT)

Who this might be right for
Newly Diagnosed Glioblastoma
TJ Biopharma Co., Ltd. 160
Testing effectiveness (Phase 2)Looking for participantsNCT05879250
What this trial is testing

WP1066 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma, IDH-WildtypeMGMT-Unmethylated Glioblastoma
Northwestern University 39
Testing effectiveness (Phase 2)Study completedNCT02465268
What this trial is testing

Vaccine Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Glioblastoma MultiformeGlioblastomaMalignant Glioma+2 more
University of Florida 175
Testing effectiveness (Phase 2)Ended earlyNCT03363659
What this trial is testing

Disulfiram and Copper Gluconate With Temozolomide in Unmethylated Glioblastoma Multiforme

Who this might be right for
GlioblastomaGlioblastoma Multiforme
Wake Forest University Health Sciences 15
Large-scale testing (Phase 3)Active Not RecruitingNCT02152982
What this trial is testing

Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
GlioblastomaGliosarcoma
National Cancer Institute (NCI) 447
Early research (Phase 1)Study completedNCT00069940
What this trial is testing

Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor

Who this might be right for
Brain and Central Nervous System TumorsGastrointestinal Stromal TumorSarcoma
Dana-Farber Cancer Institute
Large-scale testing (Phase 3)Study completedNCT02617589
What this trial is testing

An Investigational Immuno-therapy Study of Nivolumab Compared to Temozolomide, Each Given With Radiation Therapy, for Newly-diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)

Who this might be right for
Brain Cancer
Bristol-Myers Squibb 560
Testing effectiveness (Phase 2)Study completedNCT03529448
What this trial is testing

TN-TC11G (THC+CBD) Combination With Temozolomide and Radiotherapy in Patients With Newly-diagnosed Glioblastoma

Who this might be right for
Glioblastoma
Grupo Español de Investigación en Neurooncología 33
Testing effectiveness (Phase 2)Study completedNCT00099125
What this trial is testing

Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Radiation Therapy Oncology Group 170
Next Page